Cirtec Medical ("Cirtec") is a leading global provider of outsourced medical device and components design, engineering and manufacturing, headquartered in Minnesota. Cirtec specialises in outsourced solutions for active implantable and minimally invasive medical devices. Customers rely on Cirtec’s expertise to provide value-add solutions throughout the entire development and commercial manufacturing cycles to help bring life-enhancing therapies to market and scale to success.
Cirtec serves customers in the most innovative and fastest growing therapeutic end-markets and product platforms, providing significant tailwinds for growth in excess of the broader medical device outsourcing (MDO) market.
"We look forward to partnering with 3i. We feel that their approach, sector understanding and international reach makes them the right partner to support the next stage of our growth." Brian Highley, CEO, Cirtec
This transaction involved a recommendation of 3i Corporation, a US wholly owned subsidiary of 3i Group.
Havea Group is a leader in the Natural Consumer Healthcare industry in Europe. It manufactures, designs and distributes a wide range of products from functional and natural food supplements, to natural personal care products for babies and women through its world class plant in France. Havea is well positioned due to its multi-distribution channel strategy and owns several well-known brands including Vitarmonyl, Biolane, Manhaé, Ultrabiotique, Naturémoi and acquired Aragan / Synactifs and Suvéal Duo brands respectively in 2017 and 2018 to strengthen Havea's presence in the pharmacy channel.
Since inception, Havea has grown year double digit each year organically and is well positioned to benefit from the consolidation taking place in this highly fragmented market and will continue to expand its international footprint in Europe, Asia and the Americas.
"3i is a great partner for Havea; its values and approach really fits well with our entrepreneurial approach. They relentlessly look for growth while keeping the right balance with operational performance improvement, and robustness and digitalization of the core processes. In 2 years with 3i we have doubled the size of the Group, made 3 acquisitions including my own company” Nicolas Brodetzky, CEO, Havea
This transaction involved a recommendation of 3i Investments plc, advised by 3i France.
Q Holding is a leading global manufacturer of highly-engineered, fully assembled medical devices and precision-molded elastomeric components used in a broad range of Life Sciences (medical and pharmaceutical) and Electrical Management (industrial, automotive and aerospace) applications. Headquartered in Ohio, it sells products in over 50 countries and has 13 manufacturing locations in North America, EMEA and Asia.
Q Holding has built a strong reputation as the supplier of choice to provide high-quality mission critical components for medical and harsh environment applications. It has developed longstanding relationships with a broad range of blue-chip customers who value Q’s ability to design and develop customized solutions and manufacture globally.
Regulatory information: This transaction involved a recommendation of 3i Corporation, a US wholly owned subsidiary of 3i Group.